News

SMFM Announces Launch of First Annual High-Risk Pregnancy Awareness Week, June 1-8

SMFM launches its first annual High-Risk Pregnancy Awareness Week, June 1-8, a campaign to raise awareness among expectant parents and families, policymakers, researchers, and the public about high-risk pregnancies and the critical role that MFM subspecialists play in managing complex pregnancies. Continue Reading

Hypertension in Pregnancy and Postpartum: Expanding Education and Prevention Efforts to Save Lives

HDPs, including preeclampsia, superimposed preeclampsia, chronic hypertension, gestational hypertension, Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, and eclampsia, are the leading cause of maternal and infant illness and death in the United States. Continue Reading

Joint Medical Organization Response to Supreme Court Decision Preserving Access to Mifepristone

As organizations representing clinicians who care for pregnant patients, we are temporarily relieved by the Supreme Court decision to block the Fifth Circuit’s May 1 ruling and maintain the status quo, thus protecting access to mifepristone. Continue Reading

Leading Medical Organizations Respond to Recent Court Decisions on Access to Mifepristone

Healthcare access must be based on scientific evidence, not political or personal ideology. The overwhelming scientific evidence demonstrates that mifepristone is safe, effective, and critical to patient care. Mifepristone must be accessible to all whose health and lives will benefit from it. Continue Reading

When Cancer and Pregnancy Collide — Why SMFM’s New Guidance Matters

A cancer diagnosis during pregnancy is one of the most emotionally overwhelming situations that a patient and family can face. Continue Reading

SMFM Announces Neal Kovach as New Chief Executive Officer

The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Neal Kovach, MBA, has been selected as its new Chief Executive Officer (CEO) effective June 1. Continue Reading

More Than 130 Organizations Express Concern Over Changes to CDC’s Advisory Committee on Immunization

The 130+ undersigned medical, nursing, public health, and patient advocacy groups express our deep concern about the revised charter for the Advisory Committee on Immunization Practices (ACIP) published on April 9. Continue Reading

SMFM Issues New Clinical Guidance for Cancer Diagnosis and Treatment During Pregnancy

The Society for Maternal-Fetal Medicine today issued its first evidence-based clinical guidance for diagnosing and treating cancer during pregnancy, Consult Series #76. Continue Reading

Documentation of E/M with Ultrasound

Coding Tip: Documentation of E/M with Ultrasound The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; David Smith, MBA, CPC Introduction When a physician/Qualified Health Care Professional performs a significant, separately identifiable evaluation and management (E/M) service... Continue Reading

Congratulations to the 2026 SMFM Award Winners

The Society for Maternal-Fetal Medicine is pleased to announce this year’s awards presented at the SMFM 2026 Pregnancy Meeting™ in Las Vegas, NV. Continue Reading

SMFM Announces Alison G. Cahill, MD, MSCI, As New SMFM President 

The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce Alison G. Cahill, MD, MSCI, from the University of Texas at Austin Dell Medical School, as its new president for 2026-2027. Dr. Cahill will assume the SMFM presidency today at the conclusion of the 2026 Pregnancy Meeting™.  Continue Reading

New Research Finds State-Level Abortion Restrictions Associated with Increased Maternal Deaths 

The increased number of state-level abortion restrictions in the U.S. was associated with a parallel increase in maternal deaths between 2005 and 2023, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading